STRYKER CORP (SYK)
Stryker declares an $0.88 per share quarterly dividend
SILENCE THERAPEUTICS PLC (SLN)
Silence Therapeutics Highlights Recent Business Achievements and Reports First Quarter 2026 Financial Results
CELCUITY INC. (CELC)
Celcuity Schedules Release of First Quarter 2026 Financial Results and Webcast/Conference Call
VOYA FINANCIAL, INC. (VOYA)
TCIM Comments on Voya Financial’s First Quarter Earnings
PRAXIS PRECISION MEDICINES, INC. (PRAX)
Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2026 Financial Results
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Alnylam to Webcast Presentations at Upcoming Investor Conferences
FILANA THERAPEUTICS, INC. (FLNA)
Filana Therapeutics Reports Q1 2026 Financial Results and Business Update
EVEREST GROUP, LTD. (EG)
Everest Appoints Lisa Davis to Lead North America Wholesale & Specialty Business
BEACHBODY COMPANY, INC. (BODI)
Shakeology by BODi Enters Retail Stores Nationwide, Marking a Major Expansion in the Company’s Nutrition-Led Strategy
AMPHENOL CORP /DE/ (APH)
Amphenol Announces Second Quarter 2026 Dividend
BWX TECHNOLOGIES, INC. (BWXT)
BWXT Announces $1.4 Billion in Contracts for Naval Nuclear Propulsion Program
ALX ONCOLOGY HOLDINGS INC (ALXO)
ALX Oncology’s Evorpacept in Combination with Zanidatamab Generates Promising, Durable Response in Patients with Advanced HER2-Positive Breast Cancer and High CD47 Expression
REGAL REXNORD CORP (RRX)
REGAL REXNORD ANNOUNCES PARTICIPATION AT UPCOMING CONFERENCE
ARS PHARMACEUTICALS, INC. (SPRY)
ARS Pharmaceuticals Announces Conference Call and Webcast for its First Quarter 2026 Financial Results